Delivery Order SPE2DR25D2001-SPE2DR26FBGB8
- Not listed
- The Defense Logistics Agency awarded a $37,925.20 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) on December 3, 2025, with completion scheduled for December 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,188.92 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5ml) on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a $6,933.90 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5mL) on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,214.99 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5ML) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order represents a non-competed procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $2,486.37 to AmerisourceBergen Drug Corp for Rotarix Vaccine oral syringes (1.5 mL) on December 4, 2025, with an ultimate completion date of December 5, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $5,547.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5mL units). The award, issued on December 16, 2025, with an ultimate completion date of December 17, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $7,227.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 25, 2025, with an ultimate completion date of September 26, 2025. This non-set-aside contract was executed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,481.40 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5 mL) on July 8, 2025, with completion scheduled for July 9, 2025. This competitively awarded, firm fixed-price delivery order was placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract required no set-aside...
- The Defense Logistics Agency awarded a $7,507.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Rotarix vaccine in oral syringe format (1.5mL units). The contract, which is scheduled for completion by December 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation. AmerisourceBergen,...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBGB8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,122.62 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) on December 22, 2025, with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rotarix is an oral rotavirus vaccine commonly used in military and federal healthcare systems to prevent rotavirus gastroenteritis. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of pharmaceutical products and medical supplies supporting military healthcare programs and the Defense Health Agency. The company's role as a pharmaceutical prime vendor demonstrates its capability to fulfill diverse federal medical supply requirements on a global scale through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/21/25 |